Back
Apellis Pharmaceuticals Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
32.49
Seasonality Move:
18.8%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.19 | Sell |
| 20-day SMA: | 38.04 | Sell |
| 50-day SMA: | 37.88 | Sell |
| 200-day SMA: | 50 | Sell |
| 8-day EMA: | 35.96 | Sell |
| 20-day EMA: | 37.21 | Sell |
| 50-day EMA: | 38.25 | Sell |
| 200-day EMA: | 45.7 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 33.6 | Sell |
| Chaikin Money Flow: | -1084788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.37 - 40.01) | Sell |
| Bollinger Bands (100): | (36.55 - 42.35) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 32.50 while APLS 8-day simple moving average is 36.19, which is a Sell signal.
- The stock price of APLS is 32.50 while Apellis Pharmaceuticals 20-day SMA is 38.04, which makes it a Sell.
- Apellis Pharmaceuticals 50-day simple moving average is 37.88 while APLS share price is 32.50, making it a Sell technically.
- APLS stock price is 32.50 and Apellis Pharmaceuticals 200-day simple moving average is 50.00, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
3.96B
Price in USD:
32.50
Share Volume:
6.55M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
31.00
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 32.50 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 32.50 while APLS 8-day exponential moving average is 35.96, which is a Sell signal.
- The stock price of APLS is 32.50 while Apellis Pharmaceuticals 20-day EMA is 37.21, which makes it a Sell.
- Apellis Pharmaceuticals 50-day exponential moving average is 38.25 while APLS share price is 32.50, making it a Sell technically.
- APLS stock price is 32.50 and Apellis Pharmaceuticals 200-day simple moving average is 45.70, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.84, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 33.6, which suggest Apellis Pharmaceuticals is oversold
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (36.37 - 40.01), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (36.55 - 42.35), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.